Skip to content

R2P METACROSS RX BD-P50060ERRecalls & reported problems

Kaneka Corporation · R2P METACROSS RX is a Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter for peripheral indications. R2P METACROSS RX is a rapid exchange (RX) type and the maximum diameter of the compatible guidewire is 0.035 inches (0.89 mm). · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04540778166578), received between Feb 8, 2023 and Feb 8, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Deformation Due to Compressive Stress1
  • Fracture1

Patient problems

  • Foreign Body In Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 8, 2023Fracture; Deformation Due to Compressive Stress; Fracture; Deformation Due to Compressive Stress

    PROCEDURE WAS A PERIPHERAL INTERVENTION FROM RIGHT RADIAL. BALLOON GOT WRAPPED AROUND GUIDEWIRE AND GOT STUCK IN THE RADIAL ARTERY. THE BALLOON AND WIRE WERE ABLE TO BE REMOVED WITHOUT DAMAGING THE ARTERY BY PERFORMING A 2-3CM MINOR CUT DOWN IN FOREARM, AND SUTURE EVERYTHING CLOSED.

    Patient problems: Foreign Body In Patient

    MAUDE report 16326647 ↗

Other Catheter, Angioplasty, Peripheral, Transluminal devices

All Catheter, Angioplasty, Peripheral, Transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page